共 14 条
[1]
Antioxidant effect of d ipyridamole andits derivative RA-25 in m itochondria:correlation ofactivity and location in the m embrane. Nepomuceno MF,de O live ira M am ede ME,Vaz deM acedo D,et al. B ioch imB iophys Acta . 1999
[2]
Lung spec ific stealth liposom es:stab ility,b iod istribution and toxic ity of liposom alantitubercu lar drugs in m ice. Deol P,Khu ller GK. B ioch im B iophys Acta . 1997
[3]
Polym ericcarrier of proline analogue w ith antifibrotic effect inpu lmonary vascu lar remodeling. Poian i G J,Kemn itzer JE,Fox JD,et al. Am J Resp ir CritCare M ed . 1997
[4]
Preparationand antitum ar activity ofO-palm itoyldextran phosphates,O-palm itoyldextrans,and dextran phosphate. Suzuk i M,M ikam i T,M atsumoto T,et al. Carbohydrate Research . 1977
[5]
D ipyridamole-m ed iated reversal ofmu ltidrug resistance in MRP over-expressing hum an lungcarc inom a cellsin vitro. Curtin NJ,Turner DP. European Journal of Cancer . 1999
[6]
Increasedlung uptake of liposom es coated w ith polysaccharides. Takada M,Yuzuriha T,Katayam a K,et al. B ioch im B iophys Acta . 1984
[7]
Polysaccharide-coated liposom al amphoteric in B for thetreatm ent ofmurine pu lmonary cand id iasis. M iyazak i T,Kohno S,Sasayam a K,et al. Tohoku JExp M ed . 1992
[8]
L igand d irectedm acrophage targeting of amphoteric in B loaded liposom es:developm ent and characterization. Vyas SP,Katare Y,M ishra V,et al. International Journal of Pharmaceutics . 2000
[9]
The antioxidantdrug d ipyridamole spares the vitam in E and th iols in redb lood cells after oxidative stress. Kusm ic C,P icano E,Busceti CL,et al. Cardiovascular Research . 2000
[10]
Preparation of lungtargeting azithromyc in liposom es and its tissue d istributionin m ice. W ang JS,Zhu JB,Lv RQ,et al. Acta Pharm S in(药学学报) . 2005